Flu and URI F9: Summer flu or URI with acute or chronic hepatitis, liver damages, camp fever or macula typhus, fever or gastritis

1. Summer flu with fever: 298 summer flu patients were divided into a treatment group (n=218) who took F9 or its modification and a comparison group took regular medicine for seven days (n=80). Cured: 189 vs. 18 (86.69 percent vs. 22.5 percent), improved: 28 vs. 47 (12.84 percent vs. 58.75 percent) and not improved: 1 vs. 15 (0.45 percent vs. 20 percent). The treatment group was much better than the comparison group, P<0.01.

2. Acute and chronic hepatitis: 61 children in three studies took F9 or its modification for up to three weeks and 58 were cured (95.08 percent), two improved and one did not. 208 adults in two studies took F9 for the same amount of time and 203 were cured (97.59 percent) and five did not improve.

3. Acute liver damage: 63 patients were divided into a treatment group (n=42) using F9 and western medicine together and a comparison group (n=21) using western medicine only. Cured: 41 vs. 15 (97.61 percent vs. 71.42 percent), improved: 1 vs. 5 (2.38 percent vs. 23.80 percent and not improved: 0 vs. 1 (P<0.05). The average treatment time was 25.2 vs. 35.28 days, P<0.01.

4. Typhus: 108 high-fever typhus patients took F9 or its modification from one to seven days and all reported their temperatures returned to normal.

5. Gastritis: 66 patients took F9 or its modification and 51 were cured (77.27 percent), 5 significantly improved (7.57 percent), 4 improved (6.06 percent) and 6 did not improve. Several other reports also show similar results.